14-67198191-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001395907.1(GARIN2):c.30G>A(p.Met10Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,728 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395907.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARIN2 | NM_001395907.1 | c.30G>A | p.Met10Ile | missense_variant | 3/8 | ENST00000696955.1 | NP_001382836.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARIN2 | ENST00000696955.1 | c.30G>A | p.Met10Ile | missense_variant | 3/8 | NM_001395907.1 | ENSP00000512992.1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152142Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000757 AC: 19AN: 250892Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135578
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461468Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726998
GnomAD4 genome AF: 0.000296 AC: 45AN: 152260Hom.: 1 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.30G>A (p.M10I) alteration is located in exon 3 (coding exon 1) of the FAM71D gene. This alteration results from a G to A substitution at nucleotide position 30, causing the methionine (M) at amino acid position 10 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at